Neutrophilic eccrine hidradenitis.
Thorisdottir
K
K
Department of Dermatology, Cleveland Clinic Foundation, Ohio.
Tomecki
K J
KJ
Bergfeld
W F
WF
Andresen
S W
SW
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D016575:Hidradenitis / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
D003561:Cytarabine; D003630:Daunorubicin